SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-087036
Filing Date
2020-03-26
Accepted
2020-03-26 16:47:21
Documents
4
Effectiveness Date
2020-03-26

Document Format Files

Seq Description Document Type Size
1 S-8 d898891ds8.htm S-8 54207
2 EX-5.1 d898891dex51.htm EX-5.1 7312
3 EX-23.1 d898891dex231.htm EX-23.1 1900
4 GRAPHIC g898891g07v86.jpg GRAPHIC 3486
  Complete submission text file 0001193125-20-087036.txt   69405
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237410 | Film No.: 20746667
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences